Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study
- Resource Type
- Source
- Leukemia
Leukemia, 2020, Online ahead of print. ⟨10.1038/s41375-020-0991-x⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, Online ahead of print. ⟨10.1038/s41375-020-0991-x⟩ - Subject
Adult Male Cancer Research Pediatrics medicine.medical_specialty Long term follow up MEDLINE [SDV.CAN]Life Sciences [q-bio]/Cancer Cohort Studies 03 medical and health sciences Exon 0302 clinical medicine Polycythemia vera [SDV.CAN] Life Sciences [q-bio]/Cancer Biomarkers, Tumor medicine Humans article clinique Polycythemia Vera ComputingMilieux_MISCELLANEOUS Aged 030304 developmental biology 0303 health sciences Myeloproliferative Disorders business.industry Exons Hematology Janus Kinase 2 Middle Aged Prognosis medicine.disease Survival Rate Oncology Mutation Female France business Follow-Up Studies 030215 immunology - Language
- English
- ISSN
- 0887-6924
1476-5551